Related Experiment Videos
Late-onset central hypoventilation with hypothalamic dysfunction: a distinct clinical syndrome
E S Katz1, S McGrath, C L Marcus
1Eudowood Division of Pediatric Respiratory Sciences, Johns Hopkins University, Baltimore, Maryland, USA.
Pediatric Pulmonology
|December 29, 1999
Summary
Late-onset central hypoventilation syndrome (LO-CHS) with hypothalamic dysfunction (HD) is distinct from congenital central hypoventilation syndrome (CCHS). Nasal intermittent positive pressure ventilation (NIPPV) effectively treated a case of LO-CHS/HD.
Area of Science:
- Pediatric Pulmonology
- Neurology
- Endocrinology
Background:
- Idiopathic central hypoventilation can manifest after infancy as late-onset central hypoventilation syndrome (LO-CHS).
- The distinction between LO-CHS and congenital central hypoventilation syndrome (CCHS) remains unclear.
- Both syndromes are linked to neural crest tumors and typically present with a normal central nervous system.
Observation:
- Late-onset central hypoventilation syndrome (LO-CHS) has been associated with hypothalamic dysfunction (HD) in multiple case reports.
- Symptoms of hypothalamic dysfunction include hyperphagia, hypersomnolence, thermal dysregulation, emotional lability, and endocrinopathies.
- A case of LO-CHS/HD successfully treated with nasal intermittent positive pressure ventilation (NIPPV) is presented.
Findings:
- Late-onset central hypoventilation syndrome with hypothalamic dysfunction (LO-CHS/HD) exhibits distinct features from congenital central hypoventilation syndrome (CCHS).
- Key differentiating factors include the age of presentation and the presence of hypothalamic dysfunction symptoms, which are absent in CCHS.
- A literature review was conducted to delineate the full spectrum of LO-CHS/HD.
Implications:
- LO-CHS/HD is proposed as a distinct clinical entity separate from CCHS.
- Understanding LO-CHS/HD is crucial for accurate diagnosis and management in affected children.
- Nasal intermittent positive pressure ventilation (NIPPV) offers a potential treatment modality for LO-CHS/HD.